108 related articles for article (PubMed ID: 10415794)
1. Gelastatins, new inhibitors of matrix metalloproteinases from Westerdykella multispora F50733.
Lee HJ; Chung MC; Lee CH; Chun HK; Rhee JS; Kho YH
Ann N Y Acad Sci; 1999 Jun; 878():635-7. PubMed ID: 10415794
[No Abstract] [Full Text] [Related]
2. Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733.
Lee HJ; Chung MC; Lee CH; Yun BS; Chun HK; Kho YH
J Antibiot (Tokyo); 1997 Apr; 50(4):357-9. PubMed ID: 9186564
[No Abstract] [Full Text] [Related]
3. Isolation of nicotianamine as a gelatinase inhibitor.
Suzuki K; Shimada K; Nozoe S; Tanzawa K; Ogita T
J Antibiot (Tokyo); 1996 Dec; 49(12):1284-5. PubMed ID: 9031677
[No Abstract] [Full Text] [Related]
4. Phosphonate inhibitors of adamalysin II and matrix metalloproteinases.
Gallina C; Gavuzzo E; Giordano C; Gorini B; Mazza F; Paglialunga-Paradisi M; Panini G; Pochetti G; Politi V
Ann N Y Acad Sci; 1999 Jun; 878():700-2. PubMed ID: 10415812
[No Abstract] [Full Text] [Related]
5. Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Benbow U; Maitra R; Hamilton JW; Brinckerhoff CE
Ann N Y Acad Sci; 1999 Jun; 878():662-4. PubMed ID: 10415801
[No Abstract] [Full Text] [Related]
6. Development and application of a microplate assay method for the mass screening of MMP inhibitors.
Akizawa T; Uratani T; Matsukawa M; Kunimatsu A; Ito Y; Itoh M; Ohshiba Y; Yamada M; Seiki M
Ann N Y Acad Sci; 1999 Jun; 878():622-4. PubMed ID: 10415790
[No Abstract] [Full Text] [Related]
7. Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.
Sheppard GS; Florjancic AS; Giesler JR; Xu L; Guo Y; Davidsen SK; Marcotte PA; Elmore I; Albert DH; Magoc TJ; Bouska JJ; Goodfellow CL; Morgan DW; Summers JB
Bioorg Med Chem Lett; 1998 Nov; 8(22):3251-6. PubMed ID: 9873712
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors: a structure-activity study.
Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.
Groneberg RD; Burns CJ; Morrissette MM; Ullrich JW; Morris RL; Darnbrough S; Djuric SW; Condon SM; McGeehan GM; Labaudiniere R; Neuenschwander K; Scotese AC; Kline JA
J Med Chem; 1999 Feb; 42(4):541-4. PubMed ID: 10052961
[No Abstract] [Full Text] [Related]
10. Inhibition of gelatinase A by oleic acid.
Emonard H; Marcq V; Mirand C; Hornebeck W
Ann N Y Acad Sci; 1999 Jun; 878():647-9. PubMed ID: 10415797
[No Abstract] [Full Text] [Related]
11. Matrix metalloproteinases.
Johnson LL; Dyer R; Hupe DJ
Curr Opin Chem Biol; 1998 Aug; 2(4):466-71. PubMed ID: 9736919
[TBL] [Abstract][Full Text] [Related]
12. The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.
Levin JI; DiJoseph JF; Killar LM; Sharr MA; Skotnicki JS; Patel DV; Xiao XY; Shi L; Navre M; Campbell DA
Bioorg Med Chem Lett; 1998 May; 8(10):1163-8. PubMed ID: 9871728
[TBL] [Abstract][Full Text] [Related]
13. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
14. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC; Hirte HW; Singh G
Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
[TBL] [Abstract][Full Text] [Related]
15. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
Hanessian S; Moitessier N; Gauchet C; Viau M
J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
[TBL] [Abstract][Full Text] [Related]
16. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane.
Fortunato SJ; Menon R; Lombardi SJ
Am J Obstet Gynecol; 1997 Oct; 177(4):731-41. PubMed ID: 9369811
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic zip code.
Folkman J
Nat Biotechnol; 1999 Aug; 17(8):749. PubMed ID: 10429233
[No Abstract] [Full Text] [Related]
18. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis.
Graesser D; Mahooti S; Haas T; Davis S; Clark RB; Madri JA
Lab Invest; 1998 Nov; 78(11):1445-58. PubMed ID: 9840619
[TBL] [Abstract][Full Text] [Related]
19. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
20. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
